Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

NCT07463781 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma (DLBCL)
High Grade B Cell Lymphoma
Primary Mediastinal B-cell Lymphoma (PMBCL)

Interventions

OTHER: Chimeric Antigen Receptor T-cells (CAR-T) therapy

Sponsor

Fondazione Italiana Linfomi - ETS

Collaborators

[object Object]